Abstract
Homeostasis in the immune system encompasses the mechanisms governing maintenance of a functional and diverse pool of lymphocytes, thus guaranteeing immunity to pathogens while remaining self-tolerant. Antigen-naïve T cells rely on survival signals through contact with self-peptide-loaded major histocompatibility complex (MHC) molecules plus interleukin (IL)-7. Conversely, antigen-experienced (memory) T cells are typically MHC-independent and they survive and undergo periodic homeostatic proliferation through contact with both IL-7 and IL-15. Also, non-conventional γδ T cells rely on a mix of IL-7 and IL-15 for their homeostasis, whereas natural killer cells are mainly dependent on contact with IL-15. Homeostasis of CD4+ T regulatory cells is different in being chiefly regulated by contact with IL-2. Notably, increased levels of these cytokines cause expansion of responsive lymphocytes, such as found in lymphopenic hosts or following cytokine injection, whereas reduced cytokine levels cause a decline in cell numbers.
Keywords: CD4+ T cell, CD8+ T cell, NK cell, IL-4, IL-10, IL-21, Interferon, TSLP
Introduction
Throughout their lives, lymphocytes are probed for their capacity to mount efficient responses upon contact with antigen, while maintaining self-tolerance. For αβ T cell receptor (TCR)+ T cells, this process starts at their precursor stage during thymic selection and continues in the periphery in antigen-naïve and antigen-experienced (memory) T cells. Extrinsic factors, most notably common γ chain (γc) cytokines and basal TCR signals, control and maintain a stable pool size of αβ TCR+ T cells from the newborn stage up to old age. Such homeostasis also applies to other lymphocyte subsets, including γδ TCR+ T cells and natural killer (NK) cells. Below, we will provide a brief overview on the generation and activation of typical αβ TCR+ T cells (hereafter referred to as T cells), followed by a systematic review of the factors governing homeostatic survival, proliferation, and expansion of T cells and other lymphocyte subsets.
T cells are scrutinized at a precursor stage in the thymus for their capacity to receive TCR-mediated survival signals (a process termed positive selection) through contact with self-peptide-loaded major histocompatibility complex (MHC) molecules on epithelial cells in the thymic cortex; these stromal cells also produce the pro-survival cytokine interleukin (IL)-7. Subsequently, negative selection deletes T cells with high affinity for self-peptide/MHC molecules on professional antigen-presenting cells (APCs) and epithelial cells in the medulla [1]. Upon completion of these steps, mature CD4+ and CD8+ thymocytes are released into the periphery and join the pool of naïve T cells. At this stage, naïve T cells rarely, if ever, undergo cell division but continuously screen the surface of APCs in secondary lymphoid organs for their cognate antigen. Upon encounter with antigen on activated APCs, naïve T cells become fully stimulated and undergo massive proliferation and expansion, thereby giving rise to effector T cells that are able to kill target cells and release effector cytokines [2]. The majority of effector T cells are characterized by high expression of killer cell lectin-like receptor G1 (KLRG1), and most of these cells are eliminated via apoptosis upon clearance of the pathogen concerned, leaving a few antigen-specific T cells characterized by high IL-7 receptor α (CD127) surface expression to survive as memory T cells [3]. Compared to their naïve counterparts, memory T cells have the ability to mount more rapid and enhanced immune responses upon renewed contact with the same pathogen or antigenic determinant [2].
Typical memory T cells are long-lived and migrate between the secondary lymphoid organs via lymph and blood. These so-called “central” memory T cells express specific homing molecules, namely chemokine receptor CCR7 and CD62L (l-selectin), which enable their migration to the T cell zones of lymph nodes (LNs) [4]. Conversely, expression of these homing molecules is very low on another memory T cell subset found mainly in peripheral tissues and blood, termed “effector” memory T cells [4–6]. Both subsets are characterized by high surface expression of the adhesion molecule CD44 (CD44high), whereas naïve T cells have a CD44low phenotype. It should be noted that small numbers of polyclonal T cells with a memory-phenotype (MP) are found in unimmunized animals; many of these MP cells are thought to arise through contact with self-antigens [7]. Unless stated otherwise, the discussion of memory and MP T cells below refers to central rather than effector memory cells.
T cells
T cell receptor signals
Once T cells have exited the thymus, they are dependent on the same pattern of survival signals they received during their development in the thymus. In particular, survival of antigen-naïve T cells requires continued contact with self-peptide/MHC molecules, MHC class II for CD4+ T cells, and MHC class I for CD8+ T cells [8–12]. Notably, the survival signals delivered via TCR contact with self-peptide/MHC molecules are peptide specific, and there is considerable competition among naïve T cells of a given antigen specificity for contact with appropriate self-peptide/MHC molecules [13]. Significantly, this TCR-self-peptide/MHC interaction does not induce naïve T cells to proliferate and attack self, but rather, in synergy with IL-7, provides low-level signals that maintain cell survival in interphase [14, 15]. Contact with these survival factors occurs in secondary lymphoid organs, such as LNs, where professional APCs and local stromal cells provide a rich source of MHC molecules and IL-7, respectively [15–18]. In line with this model, numbers of naïve T cells are significantly reduced under conditions where homing to LNs is hampered because of decreased levels of CD62L or CCR7. Thus, antibody-mediated blocking of CD62L or deficiency of the transcription factors Kruppel-like factor 2 (KLF2) or forkhead box o1 (Foxo1) leads to reduced levels of CD62L, CCR7, and sphingosine 1 phosphate receptor 1 (S1P1), and is associated with a severe reduction in naïve T cell numbers [19–21].
In contrast to naïve T cells, memory T cell homeostasis does not require TCR contact with MHC molecules [22–25]. However, under certain circumstances, memory T cells remain dependent on peptide/MHC molecules, for example during chronic infections and autoreactive responses against self-antigens [15, 26]. The observations from acute and chronic viral infection models emphasize that memory CD8+ T cells of identical pathogen specificity rely, depending on the pathophysiological context, on distinct mechanisms to assure their maintenance. Thus, memory CD8+ T cells generated following acute infections depend on a mix of particular cytokines (see below) for their survival and homeostatic proliferation, whereas memory CD8+ T cells forming during chronic infections require contact with cognate antigen/MHC molecules [15, 25, 26].
For CD4+ T regulatory cells (Tregs), whether homeostasis of these cells requires contact with self-peptide/MHC molecules is controversial. In one study, mice expressing MHC class II molecules selectively on thymic cortical epithelial cells, but not in peripheral tissues, contained a comparably normal pool size of Tregs, suggesting that post-thymic Tregs do not require contact with self-peptide/MHC molecules [27]. Conversely, a more recent study using mice with abrogated TCR signaling capacity showed decreased homeostatic proliferation of Tregs in vivo [28].
Cytokines sharing the common γ chain receptor
The γc receptor (CD132) is a subunit of the cytokine receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, all of which play crucial roles during lymphocyte generation, survival, and homeostasis. For all γc cytokines, selectivity for individual cytokines is determined by their private α chain [29]. Moreover, for IL-2 and IL-15, a shared β subunit for the IL-2 and IL-15 receptor (CD122) is involved in cytokine binding and signaling. Cytokine binding and signaling through γc leads to the activation of different signal transduction molecules, including signal transducer and activator of transcription (STAT) 5A and 5B, Janus kinase (Jak) 1 and 3, and, in the case of pro-survival signals to T cells, favorably shifts the balance between anti-apoptotic (e.g., Bcl-2) and pro-apoptotic (e.g., Bim) molecules towards the former [29, 30]. Synthesis of γc cytokines can occur in both immune and non-immune cells. Thus, IL-2 is produced mainly by activated T cells, predominantly CD4+ T cells, in secondary lymphoid organs and, to a lesser extent, also by NK cells, NK T cells, and activated dendritic cells [31]. For IL-7, stromal cells in primary and secondary lymphoid organs secrete high amounts of IL-7 at a constant rate, followed by its presentation on extracellular matrix in these lymphoid as well as non-lymphoid organs (e.g., skin, intestine, and liver) [17, 32–34] (Fig. 1). Also, hepatocytes can produce relevant amounts of IL-7, for example upon treatment of mice with lipopolysaccharide (LPS) [33]. IL-15 is synthesized in APCs upon triggering with Toll-like receptor (TLR) agonists, such as poly(I:C) and LPS, leading to autocrine stimulation of APCs via type I interferon (IFN-I) [35]. Alternatively, IL-15 can be produced following activation of APCs with type II IFN, such as IFN-γ derived either from NK cells stimulated with IL-12 and IL-18, activated NK T cells, or effector T cells [36]. Subsequently, APCs synthesize IL-15 and transport it to their surface in association with IL-15Rα, where it is presented in trans to IL-15-sensitive T and NK cells [37] (Fig. 2). As discussed in detail in the following sections, IL-7 and IL-15 are crucial for homeostatic survival and proliferation of conventional T cells, whereas IL-2 signals are essential for the homeostasis of Tregs [38, 39].
Fig. 1.
Regulation of the IL-7 receptor α chain CD127. IL-7 (light purple dots) is usually produced at a constant rate by stromal cells residing in the primary and secondary lymphoid organs. Subsequently, IL-7 accumulates on extracellular matrix and is presented to lymphocytes, here a T cell, expressing the IL-7 receptor, composed of the γc (light brown bar) and the IL-7 receptor α chain CD127 (purple bar). Both these IL-7 receptor subunits contain cytoplasmic tails interacting with signaling molecules, such as Jak 1 and 3. Signals emerging from Jak 1 and 3 lead, via activation of STAT5A and 5B, to the upregulation of anti-apoptotic proteins such as Bcl-2 and downregulation of pro-apoptotic proteins such as Bim in mitochondria (light blue oval), thus tipping the balance in favor of pro-survival signals. Transcription of the Cd127 gene and thus upregulation of CD127 is positively influenced by contact with γc cytokines, GABPα, and Foxo1. Foxo1 enhances expression of KLF2 thus leading to upregulation of the chemokine receptor CCR7, CD62L (l-selectin), and S1P1. Conversely, under certain conditions, contact with pro-survival γc cytokines may induce activation of Gfi-1 in vitro, which either directly or via inhibition of GABPα may downregulate CD127. Moreover, strong TCR stimulation (and proliferation) may also lead to decreased CD127 expression, either directly or via activation of Gfi-1. Foxo1 forkhead box o1, Gfi-1 growth factor independence 1, Jak Janus kinase, KLF2 Kruppel-like factor 2, STAT5 signal transducer and activator of transcription 5, TCR T cell receptor, S1P 1 sphingosine 1 phosphate receptor 1, γ c common γ chain
Fig. 2.
Regulation of the IL-15 receptor β chain CD122. IL-15 (light green dots) is produced by APCs along with its α chain IL-15Rα. Upon intracellular association of IL-15 with IL-15Rα, both are transported onto the surface of the APC and presented in trans to lymphocytes, here a CD8+ T cell, expressing the dimeric IL-15 receptor, composed of the γc (light brown bar) and the IL-15 receptor β chain CD122 (light green bar). (Notably, IL-15-responsive lymphocytes may also express IL-15Rα on their own surface, which is not shown here.) Both these IL-15 receptor subunits contain cytoplasmic tails interacting with signaling molecules, such as Jak 1 and 3. Signals emerging from Jak 1 and 3 lead, via activation of STAT5A and 5B, to the upregulation of anti-apoptotic proteins such as Bcl-2 and downregulation of pro-apoptotic proteins such as Bim in mitochondria (light blue oval), thus favoring pro-survival signals. SOCS1 is able to directly inhibit the activity of Jak 1 and 3 and thus negatively influence IL-15-mediated signaling. Transcription of the Cd122 gene and thus upregulation of CD122 is positively influenced by the combined action of eomesodermin and T-bet, or by TCR stimulation (and proliferation). Conversely, Blimp-1 represses T-bet thereby negatively influencing Cd122 transcription. Contact with IL-12 or signals from APCs upon CpG binding to TLR9 on APCs (not shown) leads to inhibition of eomesodermin, whereas these signals activate T-bet. In contrast, contact with γc cytokines and TCF-1 activity positively influence eomesodermin, which favors the generation of long-lived memory CD8+ T cells, whereas Blimp-1 together with T-bet favors the generation short-lived effector CD8+ T cells. APC antigen-presenting cell, Blimp-1 B lymphocyte-induced maturation protein 1, Jak Janus kinase, SOCS-1 suppressor of cytokine signaling 1, STAT5 signal transducer and activator of transcription 5, TCF-1 T cell factor 1, TCR T cell receptor, TLR Toll-like receptor, γ c common γ chain
The major role of IL-2 in vivo appears to be in mediating development and homeostasis of Tregs, thus maintaining peripheral immune tolerance [39]. CD4+ Tregs typically express high levels of IL-2Rα (CD25) and the transcription factor Foxp3, the latter being essential for Treg function [40]. Optimal expression of Foxp3 and CD25 is dependent on contact with IL-2 [40]. Moreover, in conjunction with transforming growth factor (TGF)-β, IL-2 signals are also crucial during Treg development in the thymus, as well as for homeostatic proliferation and survival of Tregs in peripheral LNs [39–43]. Thus, IL-2−/−, CD25−/−, and CD122−/− mice, which all lack normal IL-2 signaling, show a considerable reduction in Treg numbers, thereby leading to systemic autoimmune disease in these mice [39–41]. Conversely, Treg numbers increase several-fold in lymphoid and non-lymphoid organs of mice receiving injections of IL-2 in the form of recombinant IL-2 mixed with a particular anti-IL-2 monoclonal antibody (mAb); such IL-2/anti-IL-2 mAb complexes focus IL-2 onto CD25+ cells and expand these cells [44, 45]. It should be noted that, although Tregs consume IL-2 and express a high level of CD25 under steady-state conditions, these cells do not produce IL-2 [39]. Thus, it has been suggested that Tregs might exert some of their suppressive function by consumption of IL-2 (and other pro-survival γc cytokines) via their high surface density of CD25 [31, 46]. Notably, certain other immune cells as well as some non-immune cells express CD25, albeit at much lower levels, and blocking CD25 on these cells with antibody or the use of CD25−/− mice also leads to high levels of IL-2, thereby causing strong IL-2-mediated proliferation of MP CD8+ T cells [31, 47, 48]. In contrast to IL-2, administration of IL-4 to normal mice led to a reduction of CD4+ Foxp3+ Tregs [49].
With regard to conventional T cells, several recent studies have revisited the role of IL-2 during priming of naïve T cells and shown that provision of IL-2 is important for inducing optimal T cell responses [48]. Thus, IL-2 signals during priming of naïve CD4+ and CD8+ T cells optimize expansion of these cells and allow them to survive as long-lived memory cells, in part due to IL-2-induced high expression of CD127 on the cells [50, 51]. Moreover, for CD8+ T cells, it has been shown that contact with IL-2 during primary infection with the lymphocytic choriomeningitis virus (LCMV) allows antigen-specific memory CD8+ T cells to efficiently respond to secondary challenge with the same virus [52, 53]. However, in addition to the qualitative effects of receiving IL-2 signals during priming, contact with IL-2 can have a quantitative effect on CD25 expression on effector T cells. Thus, effector T cells showing prolonged expression of high CD25 generally become short-lived effector cells, whereas the fraction of cells that upregulate CD25 for a shorter period (thereby receiving less stimulatory signals) tend to survive as long-lived memory cells [51, 54]. At the memory stage, administration of recombinant IL-2 to mice 2 months following LCMV infection has been shown to mediate proliferation and expansion of virus-specific memory CD8+ T cells and also, to a lesser degree, CD4+ T cells [55, 56]. Vigorous expansion of LCMV-specific memory CD8+ T cells and also naturally occurring MP CD8+ T cells was observed upon adoptive transfer of these cells to normal mice treated with IL-2/anti-IL-2 mAb complexes [44, 57]. These observations are in line with studies on antigen-specific CD8+ T cells from mice lacking the co-inhibitory molecule B and T lymphocyte attenuator (BTLA, CD272). Thus, BTLA−/− CD8+ T cells showed enhanced primary and secondary antigen responses in vivo, presumably reflecting that BTLA engagement inhibits IL-2 secretion by T cells [58, 59].
Besides its essential contribution to B cell development (in mice), IL-7 in concert with tonic TCR signals has a crucial role in maintaining the survival of naïve CD4+ and CD8+ T cells in interphase. IL-7 also contributes to the survival and intermittent homeostatic proliferation of memory T cells [56, 60, 61] (Fig. 3). Thus, it is not surprising that virtually all T cells express high levels of IL-7Rα (CD127). Downregulation of CD127 occurs following TCR engagement in vivo or after contact with IL-2, IL-4, IL-6, IL-7, or IL-15 in vitro [62–64], although the role of these cytokines in decreasing CD127 levels in vivo is controversial [44, 65, 66]. Conversely, several transcription factors including Foxo1 and GA binding protein α (GABPα) have been implicated in the upregulation of CD127 in T cells (Fig. 1), as well as PU.1 in pre-B cells [20, 67, 68]. Moreover, the transcription factor growth factor independence (Gfi)-1 has been reported to repress CD127 in CD8+ T cells by antagonizing GABPα following TCR signals in vivo or contact with IL-2, IL-4, IL-6, IL-7, or IL-15 in vitro [64, 69].
Fig. 3.
Factors involved in the homeostasis of T cells and NK cells. Lymphocyte subsets are depicted in different colors (blue conventional CD4+ and CD8+ T cells; red Treg; light orange γδ T cell; light brown NK cell), along with their expression of CD25 (IL-2Rα orange bar), CD122 (IL-15Rβ light green bar), and CD127 (IL-7Rα purple bar). Expression levels of these cytokine receptors on these lymphocyte subsets are indicated by the size of the bars as low (or background), intermediate, or high. Homeostatic survival and expansion of naïve CD4+ and CD8+ T cells depends on IL-7 and MHC molecules, whereas their homeostatic proliferation requires IL-7 signals. Other cytokines able to stimulate naïve T cells, e.g., upon injection into mice, are IFN-I (i.e., IFN-α/β), IFN-γ, and TSLP, as well as, for naïve CD8+ T cells, also IL-2, IL-15, IL-21, and IL-12. Homeostasis of typical memory CD4+ T cells is governed by IL-7 (and IL-15) signals, whereas contact with IL-15 and IL-7 is responsible for homeostasis of typical memory CD8+ T cells, which can also be boosted by administration of other γc cytokines and IFN-I. Tregs rely on IL-2 for homeostatic survival and proliferation, while their homeostatic expansion is dependent on IL-7 and probably also IL-2. For γδ T cells, contact with mainly IL-15 and also IL-7 is responsible for their maintenance, whereas IL-15 signals are crucial for NK cell homeostasis. IFN-I type I interferon, MHC major histocompatibility complex, MHC-I MHC class I, MHC-II MHC class II, NK natural killer, Treg T regulatory cell, TSLP thymic stromal lymphopoietin, γ c common γ chain
Interestingly, IL-7 signals also influence lymphoid tissue inducer cells, which are crucial for the development of secondary lymphoid organs, including LNs and Peyer’s patches. Lymphoid tissue inducer cells are retinoic acid-related orphan receptor (ROR)γt+ CD4+ CD3− cells in the gut. It has been shown that these cells depend on IL-7 signals, and that increased IL-7 signals lead to the expansion of these cells in vivo [70–72].
Unlike IL-7, responsiveness to IL-15 (and IL-2) is controlled by expression of CD122, the IL-2/IL-15Rβ subunit. Expression of CD122 is regulated by many factors, including upregulation following TCR stimulation. In particular, the T-box transcription factor eomesodermin in conjunction with T-bet ensures maintenance of high CD122 levels on long-lived MP CD8+ T cells [73, 74]. Eomesodermin is influenced positively by the transcription factor T cell factor (TCF)-1 as well as by γc cytokine signals, whereas inflammatory stimuli (such as IL-12 and CpG) have been found to repress eomesodermin but induce T-bet expression; conversely, T-bet together with B lymphocyte-induced maturation protein (Blimp)-1 favors the generation of short-lived effector CD8+ T cells [51, 75–81] (Fig. 2). CD122 expression is highest on both memory and MP CD8+ T cells, as well as on NK cells and certain other lymphoid subsets [35, 57, 82]. Accordingly, IL-15 signals are crucial for the homeostatic proliferation and survival of each of these subsets (Fig. 3). Contact with IL-15 occurs in several sites, including the bone marrow, spleen, and LNs, as well as liver [82–87]. The importance of IL-15 is indicated by the finding that animals deficient in IL-15 production (IL-15−/− mice) or IL-15Rα-mediated trans-presentation of IL-15 (IL-15Rα−/− mice) show a considerable reduction in numbers of resting MP CD8+ T cells, NK cells, NK T cells, and intraepithelial lymphocytes; these findings reflect that IL-15 is required largely for proliferation and expansion of these cells rather than for their initial formation [83, 88–90]. Conversely, increasing IL-15 signals in vivo, for example by injecting recombinant IL-15 or the use of IL-15 transgenic animals, causes considerable expansion of MP CD8+ T cells and NK cells [91–96].
IL-21, which is mainly produced by CD4+ T cells, is able to act on CD8+ T cells, either by itself or in synergy with IL-15 (see below), to enhance CD8+ T cell responses or counts [97–99]. Recently, IL-21 signals delivered to CD8+ T cells during viral infection were found to be important for the formation of memory CD8+ T cells [100]. Moreover, for memory CD8+ T cells forming during chronic virus infections, IL-21 signals were able to prevent rapid exhaustion of these cells, thus helping to control the virus [101–103]. However, injection of IL-21 did not accelerate homeostatic proliferation of memory CD4+ and CD8+ T cells generated following acute virus infections [56].
Notably, some γc cytokines can act in synergy with other γc cytokines. Thus, in contrast to IL-15 alone, which has little effect on naïve CD8+ T cells at physiological concentrations [35], a combination of exogenous IL-15 and IL-21 is able to induce proliferation not only of memory but also naïve CD8+ T cells in vitro and lead to increased CD8+ T cell-mediated anti-tumor activity in vivo [98]. Also, IL-15 signals can be supplemented or compensated for by high concentrations of other γc cytokines, such as by injecting IL-2, IL-4, or raising IL-7 levels in IL-7 transgenic mice. These situations lead to marked increases in numbers of MP CD8+ T cells, even in IL-15−/− mice. Except in IL-7 transgenic mice, elevating the level of γc cytokines induces rapid proliferation, as distinct from the slow intermittent proliferation, characteristic of normal MP T cell homeostasis [44, 104]. For IL-7, high levels of thymic stromal lymphopoietin (TSLP), which does not bind to γc but to CD127 and the TSLP receptor, can compensate for a lack of IL-7 in T cell homeostasis in vivo [105, 106].
Increased availability of γc cytokines, especially IL-7 and to a lesser degree IL-15, is found during lymphopenia, which occurs naturally in the neonatal period of mice or upon removal of T and B cells from adults, for example following whole body irradiation [15, 107]. Lymphopenia reduces consumption of IL-7 (and IL-15), thereby increasing its availability to residual T cells and after adoptive T cell transfer to lymphopenic hosts [15, 108]. As a result, both conventional T cells and Tregs are subjected to increased IL-7 (and IL-15) signaling, thereby causing the cells to undergo acute “homeostatic” proliferation, also termed homeostatic expansion or lymphopenia-induced proliferation [109–112]. For naïve T cells, homeostatic expansion is dependent not only on IL-7 but also on TCR contact with self-peptide/MHC complexes. Following homeostatic expansion, naïve T cells acquire the phenotypic and functional properties of memory T cells. As mentioned earlier, most MP T cells may be self-reactive and represent the progeny of naïve T cells responding to self-antigens during episodes of homeostatic expansion [7, 109–111, 113, 114]. Interestingly, lack of suppressor of cytokine signaling (SOCS)-1 renders naïve CD8+ T cells hyperresponsive to IL-15 signals, thus causing self-peptide/MHC molecule-dependent “homeostatic expansion” even under non-lymphopenic conditions [115, 116]. Moreover, under conditions where in vivo levels of either IL-2 or IL-15 are elevated, naïve T cells undergo a form of homeostatic expansion that is MHC-dependent, but much more rapid than the typical pattern of slow homeostatic expansion driven by IL-7 [117]. In addition to cytokines and self-peptide/MHC molecules, homeostatic expansion of T cells can be influenced by other factors such as expression of lymphocyte activation gene-3 (LAG-3, CD223), BTLA (CD272), the transmembrane adaptor protein SIT, and heat-stable antigen (CD24). Thus, homeostatic expansion of LAG-3-, BTLA-, or SIT-deficient naïve CD8+ T cells is faster and more intense than for normal cells [59, 118, 119]. Conversely, CD24-deficient T cells show a considerable reduction in their tempo of proliferation during homeostatic expansion [120]. For homeostatic expansion of memory T cells, it should be mentioned that these cells are heavily dependent on contact with both IL-7 and IL-15, but do not require interaction with peptide/MHC molecules [15].
Other cytokines
As mentioned above, IFNs, particularly IFN-α/β (IFN-I), can lead to IL-15 production by APCs and thereby induce proliferation of memory and MP CD8+ T cells. In addition, IFN-I is also able to act directly on naïve antigen-specific CD8+ and CD4+ T cells and promote expansion and survival of these cells during an immune response, such as following infection with LCMV [121, 122]. This direct action of IFN-I provides a so-called “third signal” to the responding T cells and can also be delivered by IL-12 [123]. In certain situations, however, IFN-I might exert a negative role on CD8+ T cells following viral infection, particularly on memory CD8+ T cells [124]. With regard to other cytokines, IFN-γ has been found to resemble IFN-I in being able to act directly on naïve CD8+ and CD4+ T cells by improving antigen-mediated expansion of these cells [125, 126] (Fig. 3).
Certain cytokines, notably TGF-β and IL-10, are produced by some Tregs and can have a marked inhibitory action on T cells, although data from recent years have shown that the contribution of these cytokines to the quality of the immune response is highly variable, especially for CD8+ T cells [127]. Thus, in certain situations, IL-10 can boost expansion and memory formation of antigen-specific CD8+ T cells, for example during acute bacterial infection [128, 129]. However, during prolonged immune responses, IL-10 seems to be suppressive. Thus, in chronic LCMV infection, it was found that blocking IL-10 production, either by genetic removal or injection of antibody, reversed the anergic phenotype of antigen-specific CD8+ and CD4+ effector T cells, thereby leading to virus clearance and the generation of functional antigen-specific memory T cells [130, 131].
For TGF-β, this cytokine has a role in regulating the survival and differentiation of Tregs and effector CD4+ T cells [39, 132]. Conversely, for CD8+ T cells, TGF-β signals might influence responsiveness of CD8+ T cells to homeostatic cues, such as TCR and cytokine signals [132]. Thus, T cell-targeted deletion of the TGF-β receptor II led to the emergence of activated, effector-like CD62Llow CD44high CD8+ T cells undergoing rapid homeostatic proliferation [132]. Based on these characteristics, TGF-β receptor-deficient CD8+ T cells display features of memory T cells that continue to interact with their cognate (self-)antigen. Interestingly, a recent study showed that attenuation of TGF-β signaling in T cells resulted in a reversal of the anergic phenotype of antigen-specific memory CD8+ T cells generated during a chronic viral infection, thus leading to eradication of the virus [133].
γδ T cells
T cells expressing γδ TCRs are non-conventional T cells that recognize non-peptide antigens, which are upregulated upon tissue stress [134, 135]. Recognition of these stress-induced molecules by γδ T cells is achieved via binding of their (semi-)invariant γδ TCRs in addition to triggering of other stimulatory molecules, such as TLRs. In addition to being present in secondary lymphoid organs and the liver, γδ T cells reside in epithelial surfaces, such as the skin and the mucosa of the respiratory, digestive, and reproductive systems [134, 135]. Homeostasis of γδ T cells has been reported to require contact with cytokines, but not with MHC molecules. Thus, γc cytokines, notably IL-7 and IL-15, have been implicated in mediating these processes, as mice deficient in these cytokines or their receptors lack (subsets) of γδ T cells [89, 136–139]. Accordingly, γδ T cells express high levels of CD127 and CD122 [140]. Similar to αβ TCR+ T cells and NK cells, injection of γδ T cells to lymphopenic hosts also lacking γδ T cells leads to homeostatic expansion of transferred γδ T cells, which is driven by IL-15 and IL-7 [140, 141]. Thus, γδ T cells compete for the same cytokine signals as T cells, notably CD8+ αβ TCR+ T cells, and NK cells during homeostatic expansion, while contact with MHC molecules does not seem to be required for such expansion [141]. Interestingly, an NK1.1+ subset of γδ T cells shows a slower rate of homeostatic expansion, compared to CD8+ γδ T cells [142]
Natural killer cells
IL-2 is known as a potent NK cell stimulatory factor, both in vitro and in vivo, and NK cells expand considerably following treatment with CD122-specific IL-2/anti-IL-2 mAb complexes, similar to MP CD8+ T cells [44, 57, 143]. However, IL-2 probably plays only a minor role in the steady-state homeostasis of NK cells, in contrast to IL-15, which is crucial for survival and homeostatic proliferation of NK cells under normal conditions [144] (Fig. 3). As mentioned above, IL-15−/− and IL-15Rα−/− mice both lack NK cells, whereas increased IL-15 signals in vivo lead to expansion of NK cells [89–95]. Conversely, the peripheral pool size of NK cells in IL-2−/− IL-4−/− IL-7−/− triple-deficient mice on a recombinase-activating gene (RAG)−/− background is normal and functional, thus showing that these γc cytokines are dispensable for NK cell generation and survival [145]. Interestingly, IL-15-mediated expansion of NK cells is antagonized by IL-21 in vitro, whereas NK cells receiving IL-21 signals show enhanced cytotoxicity and IFN-γ production upon stimulation with poly(I:C) in vivo or IL-15 in vitro [146].
Similar to T cells, NK cells undergo expansion upon transfer to lymphopenic mice and, like MP T cells, acquire characteristics of long-lived memory cells [147]. However, such “homeostatic expansion” requires adoptive transfer of NK cells to NK cell-deficient mice, notably RAG−/− γ−/−c double knockout mice. Such RAG−/− γ−/−c mice probably contain increased cytokine levels of both IL-7 and IL-15, reflecting a lack of consumption of these cytokines [144, 148]. Moreover, in very young mice, i.e., at the age of 1 month or less, turnover of NK cells is considerably increased, suggesting that NK cells, like MP CD8+ T cells, undergo homeostatic expansion [149]. Such expansion of NK cells probably depends largely on contact with IL-15, with little or no role for IL-7 or other γc cytokines [145]. Interestingly, KLRG+ NK cells show poor IL-15 responses in terms of homeostatic proliferation and homeostatic expansion [148]. Also, MHC class I molecules do not seem to be involved in homeostatic NK cell expansion [149].
IL-12 and IL-18 are able to activate NK cells when added in vitro. However, neither of these cytokines nor IFNs have been implicated in the normal homeostasis of NK cells in vivo. Likewise, there is no evidence that NK cell homeostasis involves TGF-β or IL-10.
Concluding remarks and summary
Collectively, homeostasis of lymphocytes is governed by cytokines, most notably γc cytokines, and, for some lymphocytes, also signals received from antigen-receptors (Fig. 3). Thus, homeostatic survival and homeostatic expansion of naïve CD4+ and CD8+ T cells depends on IL-7 and self-peptide/MHC molecules, whereas homeostatic proliferation of these cells requires IL-7 (and IL-15) signals. Other cytokines able to stimulate naïve CD4+ T cells are IFNs and TSLP, whereas naïve CD8+ T cells can also be stimulated with increased levels of IL-2, IL-15, IL-21, and IL-12.
Homeostasis of typical (central) memory and MP CD4+ T cells is governed by IL-7 (and IL-15) signals, whereas contact with IL-15 and IL-7 is responsible for homeostasis of typical (central) memory and MP CD8+ T cells. Elevated levels of other γc cytokines, e.g., following injection of recombinant cytokine or IFN-I, are able to boost numbers of memory CD8+ T cells, while enhanced IL-2 signals can lead to an increase in memory CD4+ T cell counts. Notably, both MP cells and memory CD8+ T cells generated by homeostatic proliferation closely resemble antigen-specific memory CD8+ T cells formed during responses to pathogens; thus, all these CD8+ T subsets are long-lived and dependent on IL-7 and IL-15 [15, 25, 56]. Also, MP CD4+ T cells are similar to pathogen-specific memory CD4+ T cells in being dependent on IL-7 (and IL-15) signals [15, 25, 56, 150] (Fig. 3). However, unlike memory CD8+ T cells, the frequency of pathogen-specific memory CD4+ T cells tends to decrease with time [13, 151, 152]. The precise cause of this decline remains unclear.
In contrast to the above-mentioned T cell subsets, CD4+ Tregs rely on IL-2 signals for their homeostatic survival and proliferation. Homeostatic expansion of CD4+ Tregs in lymphopenic hosts is driven by elevated IL-7 levels and probably also depends on paracrine IL-2 signals from activated T cells. Interestingly, it has been suggested that strong IL-15 signals might also impact on Tregs and lead to their expansion [153].
Similar to memory CD8+ T cells, homeostasis of γδ T cells relies on contact with mainly IL-15 and also IL-7. For NK cells, IL-15 signals are crucial for their homeostatic maintenance under steady-state conditions. Furthermore, increased IL-2 levels are well known to potently activate and expand NK cells.
Abbreviations
- APC
Antigen-presenting cell
- Blimp-1
B lymphocyte-induced maturation protein 1
- BTLA
B and T lymphocyte attenuator
- Foxo1
Forkhead box o1
- Foxp3
Forkhead box p3
- GABPα
GA binding protein α
- Gfi-1
Growth factor independence 1
- IFN
Interferon
- IL
Interleukin
- Jak
Janus kinase
- KLF2
Kruppel-like factor 2
- KLRG1
Killer cell lectin-like receptor G1
- LCMV
Lymphocytic choriomeningitis virus
- LN
Lymph node
- LPS
Lipopolysaccharide
- MHC
Major histocompatibility complex
- MP
Memory-phenotype
- NK
Natural killer
- RAG
Recombinase-activating gene
- S1P1
Sphingosine 1 phosphate receptor 1
- SOCS-1
Suppressor of cytokine signaling 1
- STAT5
Signal transducer and activator of transcription 5
- TCF-1
T cell factor 1
- TCR
T cell receptor
- TGF-β
Transforming growth factor-β
- TLR
Toll-like receptor
- Treg
T regulatory cell
- TSLP
Thymic stromal lymphopoietin
- γc
Common γ chain
References
- 1.Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol. 2005;5(10):772–782. doi: 10.1038/nri1707. [DOI] [PubMed] [Google Scholar]
- 2.Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science. 1996;272(5258):54–60. doi: 10.1126/science.272.5258.54. [DOI] [PubMed] [Google Scholar]
- 3.Sallusto F, Lanzavecchia A, Araki K, Ahmed R. From vaccines to memory and back. Immunity. 2010;33(4):451–463. doi: 10.1016/j.immuni.2010.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–763. doi: 10.1146/annurev.immunol.22.012703.104702. [DOI] [PubMed] [Google Scholar]
- 5.Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291(5512):2413–2417. doi: 10.1126/science.1058867. [DOI] [PubMed] [Google Scholar]
- 6.Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 2001;410(6824):101–105. doi: 10.1038/35065111. [DOI] [PubMed] [Google Scholar]
- 7.Sprent J, Surh CD. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol. 2011;12(6):478–484. doi: 10.1038/ni.2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Takeda S, Rodewald HR, Arakawa H, Bluethmann H, Shimizu T. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity. 1996;5(3):217–228. doi: 10.1016/s1074-7613(00)80317-9. [DOI] [PubMed] [Google Scholar]
- 9.Labrecque N, Whitfield LS, Obst R, Waltzinger C, Benoist C, Mathis D. How much TCR does a T cell need? Immunity. 2001;15(1):71–82. doi: 10.1016/s1074-7613(01)00170-4. [DOI] [PubMed] [Google Scholar]
- 10.Polic B, Kunkel D, Scheffold A, Rajewsky K. How alpha beta T cells deal with induced TCR alpha ablation. Proc Natl Acad Sci USA. 2001;98(15):8744–8749. doi: 10.1073/pnas.141218898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Martin B, Becourt C, Bienvenu B, Lucas B. Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment. Blood. 2006;108(1):270–277. doi: 10.1182/blood-2006-01-0017. [DOI] [PubMed] [Google Scholar]
- 12.Takada K, Jameson SC. Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels. J Exp Med. 2009;206(10):2253–2269. doi: 10.1084/jem.20082553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hataye J, Moon JJ, Khoruts A, Reilly C, Jenkins MK. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science. 2006;312(5770):114–116. doi: 10.1126/science.1124228. [DOI] [PubMed] [Google Scholar]
- 14.Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol. 2009;9(12):823–832. doi: 10.1038/nri2657. [DOI] [PubMed] [Google Scholar]
- 15.Boyman O, Letourneau S, Krieg C, Sprent J. Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol. 2009;39(8):2088–2094. doi: 10.1002/eji.200939444. [DOI] [PubMed] [Google Scholar]
- 16.Brocker T. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med. 1997;186(8):1223–1232. doi: 10.1084/jem.186.8.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, Cyster JG, Luther SA. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol. 2007;8(11):1255–1265. doi: 10.1038/ni1513. [DOI] [PubMed] [Google Scholar]
- 18.Jung YW, Rutishauser RL, Joshi NS, Haberman AM, Kaech SM. Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection. J Immunol. 2010;185(9):5315–5325. doi: 10.4049/jimmunol.1001948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, Walsh ER, Wani MA, Lingrel JB, Hogquist KA, Jameson SC. Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature. 2006;442(7100):299–302. doi: 10.1038/nature04882. [DOI] [PubMed] [Google Scholar]
- 20.Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, DePinho RA, Hedrick SM. Foxo1 links homing and survival of naive T cells by regulating l-selectin, CCR7 and interleukin 7 receptor. Nat Immunol. 2009;10(2):176–184. doi: 10.1038/ni.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ouyang W, Beckett O, Flavell RA, Li MO. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity. 2009;30(3):358–371. doi: 10.1016/j.immuni.2009.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Swain SL, Hu H, Huston G. Class II-independent generation of CD4 memory T cells from effectors. Science. 1999;286(5443):1381–1383. doi: 10.1126/science.286.5443.1381. [DOI] [PubMed] [Google Scholar]
- 23.Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, Ahmed R. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 1999;286(5443):1377–1381. doi: 10.1126/science.286.5443.1377. [DOI] [PubMed] [Google Scholar]
- 24.Leignadier J, Hardy MP, Cloutier M, Rooney J, Labrecque N. Memory T-lymphocyte survival does not require T-cell receptor expression. Proc Natl Acad Sci USA. 2008;105(51):20440–20445. doi: 10.1073/pnas.0806289106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Surh CD, Boyman O, Purton JF, Sprent J. Homeostasis of memory T cells. Immunol Rev. 2006;211:154–163. doi: 10.1111/j.0105-2896.2006.00401.x. [DOI] [PubMed] [Google Scholar]
- 26.Shin H, Blackburn SD, Blattman JN, Wherry EJ. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med. 2007;204(4):941–949. doi: 10.1084/jem.20061937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med. 2001;194(4):427–438. doi: 10.1084/jem.194.4.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kim JK, Klinger M, Benjamin J, Xiao Y, Erle DJ, Littman DR, Killeen N. Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking. PLoS One. 2009;4(8):e6580. doi: 10.1371/journal.pone.0006580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9(7):480–490. doi: 10.1038/nri2580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hildeman D, Jorgensen T, Kappler J, Marrack P. Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol. 2007;19(5):516–521. doi: 10.1016/j.coi.2007.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Letourneau S, Krieg C, Pantaleo G, Boyman O. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J Allergy Clin Immunol. 2009;123(4):758–762. doi: 10.1016/j.jaci.2009.02.011. [DOI] [PubMed] [Google Scholar]
- 32.Tokoyoda K, Zehentmeier S, Hegazy AN, Albrecht I, Grun JR, Lohning M, Radbruch A. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity. 2009;30(5):721–730. doi: 10.1016/j.immuni.2009.03.015. [DOI] [PubMed] [Google Scholar]
- 33.Sawa Y, Arima Y, Ogura H, Kitabayashi C, Jiang JJ, Fukushima T, Kamimura D, Hirano T, Murakami M. Hepatic interleukin-7 expression regulates T cell responses. Immunity. 2009;30(3):447–457. doi: 10.1016/j.immuni.2009.01.007. [DOI] [PubMed] [Google Scholar]
- 34.Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol. 2005;174(11):6571–6576. doi: 10.4049/jimmunol.174.11.6571. [DOI] [PubMed] [Google Scholar]
- 35.Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 1998;8(5):591–599. doi: 10.1016/s1074-7613(00)80564-6. [DOI] [PubMed] [Google Scholar]
- 36.Boyman O. Bystander activation of CD4+ T cells. Eur J Immunol. 2010;40(4):936–939. doi: 10.1002/eji.201040466. [DOI] [PubMed] [Google Scholar]
- 37.Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. Immunity. 2002;17(5):537–547. doi: 10.1016/s1074-7613(02)00429-6. [DOI] [PubMed] [Google Scholar]
- 38.Boyman O, Purton JF, Surh CD, Sprent J. Cytokines and T-cell homeostasis. Curr Opin Immunol. 2007;19(3):320–326. doi: 10.1016/j.coi.2007.04.015. [DOI] [PubMed] [Google Scholar]
- 39.Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity. 2010;33(2):153–165. doi: 10.1016/j.immuni.2010.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6(11):1142–1151. doi: 10.1038/ni1263. [DOI] [PubMed] [Google Scholar]
- 41.Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 2002;17(2):167–178. doi: 10.1016/s1074-7613(02)00367-9. [DOI] [PubMed] [Google Scholar]
- 42.Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, Mathis D, Benoist C, Rudensky AY. Stability of the regulatory T cell lineage in vivo. Science. 2010;329(5999):1667–1671. doi: 10.1126/science.1191996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Barron L, Dooms H, Hoyer KK, Kuswanto W, Hofmann J, O’Gorman WE, Abbas AK. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol. 2010;185(11):6426–6430. doi: 10.4049/jimmunol.0903940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J. Selective stimulation of T cell subsets with antibody–cytokine immune complexes. Science. 2006;311(5769):1924–1927. doi: 10.1126/science.1122927. [DOI] [PubMed] [Google Scholar]
- 45.Webster KE, Walters S, Kohler RE, Mrkvan T, Boyman O, Surh CD, Grey ST, Sprent J. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med. 2009;206(4):751–760. doi: 10.1084/jem.20082824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007;8(12):1353–1362. doi: 10.1038/ni1536. [DOI] [PubMed] [Google Scholar]
- 47.Letourneau S, van Leeuwen EM, Krieg C, Martin C, Pantaleo G, Sprent J, Surh CD, Boyman O. IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25. Proc Natl Acad Sci USA. 2010;107(5):2171–2176. doi: 10.1073/pnas.0909384107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Boyman O, Cho JH, Sprent J. The role of interleukin-2 in memory CD8 cell differentiation. Adv Exp Med Biol. 2010;684:28–41. doi: 10.1007/978-1-4419-6451-9_3. [DOI] [PubMed] [Google Scholar]
- 49.Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Ruckert B, Karagiannidis C, Lambrecht BN, Hendriks RW, Crameri R, Akdis CA, Blaser K, Schmidt-Weber CB. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007;5(12):e329. doi: 10.1371/journal.pbio.0050329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Dooms H, Wolslegel K, Lin P, Abbas AK. Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7R alpha-expressing cells. J Exp Med. 2007;204(3):547–557. doi: 10.1084/jem.20062381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, Bevan MJ, Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity. 2010;32(1):79–90. doi: 10.1016/j.immuni.2009.11.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 2006;441(7095):890–893. doi: 10.1038/nature04790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Bachmann MF, Wolint P, Walton S, Schwarz K, Oxenius A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur J Immunol. 2007;37(6):1502–1512. doi: 10.1002/eji.200637023. [DOI] [PubMed] [Google Scholar]
- 54.Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, Ahmed R. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity. 2010;32(1):91–103. doi: 10.1016/j.immuni.2009.11.010. [DOI] [PubMed] [Google Scholar]
- 55.Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med. 2003;9(5):540–547. doi: 10.1038/nm866. [DOI] [PubMed] [Google Scholar]
- 56.Lenz DC, Kurz SK, Lemmens E, Schoenberger SP, Sprent J, Oldstone MB, Homann D. IL-7 regulates basal homeostatic proliferation of antiviral CD4+ T cell memory. Proc Natl Acad Sci USA. 2004;101(25):9357–9362. doi: 10.1073/pnas.0400640101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Krieg C, Letourneau S, Pantaleo G, Boyman O. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc Natl Acad Sci USA. 2010;107(26):11906–11911. doi: 10.1073/pnas.1002569107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Krieg C, Han P, Stone R, Goularte OD, Kaye J. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175(10):6420–6427. doi: 10.4049/jimmunol.175.10.6420. [DOI] [PubMed] [Google Scholar]
- 59.Krieg C, Boyman O, Fu YX, Kaye J. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat Immunol. 2007;8(2):162–171. doi: 10.1038/ni1418. [DOI] [PubMed] [Google Scholar]
- 60.Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1(5):426–432. doi: 10.1038/80868. [DOI] [PubMed] [Google Scholar]
- 61.Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA. 2001;98(15):8732–8737. doi: 10.1073/pnas.161126098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4(12):1191–1198. doi: 10.1038/ni1009. [DOI] [PubMed] [Google Scholar]
- 63.Huster KM, Busch V, Schiemann M, Linkemann K, Kerksiek KM, Wagner H, Busch DH. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci USA. 2004;101:5610–5615. doi: 10.1073/pnas.0308054101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A. Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity. 2004;21(2):289–302. doi: 10.1016/j.immuni.2004.07.016. [DOI] [PubMed] [Google Scholar]
- 65.Boyman O, Ramsey C, Kim DM, Sprent J, Surh CD. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia. J Immunol. 2008;180(11):7265–7275. doi: 10.4049/jimmunol.180.11.7265. [DOI] [PubMed] [Google Scholar]
- 66.Klonowski KD, Williams KJ, Marzo AL, Lefrancois L. Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol. 2006;177(7):4247–4251. doi: 10.4049/jimmunol.177.7.4247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.DeKoter RP, Lee HJ, Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity. 2002;16(2):297–309. doi: 10.1016/s1074-7613(02)00269-8. [DOI] [PubMed] [Google Scholar]
- 68.Xue HH, Bollenbacher J, Rovella V, Tripuraneni R, Du YB, Liu CY, Williams A, McCoy JP, Leonard WJ. GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells. Nat Immunol. 2004;5(10):1036–1044. doi: 10.1038/ni1117. [DOI] [PubMed] [Google Scholar]
- 69.Chandele A, Joshi NS, Zhu J, Paul WE, Leonard WJ, Kaech SM. Formation of IL-7Ralphahigh and IL-7Ralphalow CD8 T cells during infection is regulated by the opposing functions of GABPalpha and Gfi-1. J Immunol. 2008;180(8):5309–5319. doi: 10.4049/jimmunol.180.8.5309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Luther SA, Ansel KM, Cyster JG. Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development. J Exp Med. 2003;197(9):1191–1198. doi: 10.1084/jem.20021294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Meier D, Bornmann C, Chappaz S, Schmutz S, Otten LA, Ceredig R, Acha-Orbea H, Finke D. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity. 2007;26(5):643–654. doi: 10.1016/j.immuni.2007.04.009. [DOI] [PubMed] [Google Scholar]
- 72.Schmutz S, Bosco N, Chappaz S, Boyman O, Acha-Orbea H, Ceredig R, Rolink AG, Finke D. Cutting edge: IL-7 regulates the peripheral pool of adult RORgamma + lymphoid tissue inducer cells. J Immunol. 2009;183(4):2217–2221. doi: 10.4049/jimmunol.0802911. [DOI] [PubMed] [Google Scholar]
- 73.Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, Palanivel VR, Mullen AC, Gasink CR, Kaech SM, Miller JD, Gapin L, Ryan K, Russ AP, Lindsten T, Orange JS, Goldrath AW, Ahmed R, Reiner SL. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol. 2005;6(12):1236–1244. doi: 10.1038/ni1268. [DOI] [PubMed] [Google Scholar]
- 74.Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol. 2010;185(9):4988–4992. doi: 10.4049/jimmunol.1002042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Zhou X, Yu S, Zhao DM, Harty JT, Badovinac VP, Xue HH. Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity. 2010;33(2):229–240. doi: 10.1016/j.immuni.2010.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Jeannet G, Boudousquie C, Gardiol N, Kang J, Huelsken J, Held W. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc Natl Acad Sci USA. 2010;107(21):9777–9782. doi: 10.1073/pnas.0914127107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Decaluwe H, Taillardet M, Corcuff E, Munitic I, Law HK, Rocha B, Riviere Y, Di Santo JP. Gamma(c) deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors. Proc Natl Acad Sci USA. 2010;107(20):9311–9316. doi: 10.1073/pnas.0913729107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, Hagman J, Gapin L, Kaech SM. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281–295. doi: 10.1016/j.immuni.2007.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Takemoto N, Intlekofer AM, Northrup JT, Wherry EJ, Reiner SL. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J Immunol. 2006;177(11):7515–7519. doi: 10.4049/jimmunol.177.11.7515. [DOI] [PubMed] [Google Scholar]
- 80.Kallies A, Xin A, Belz GT, Nutt SL. Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses. Immunity. 2009;31(2):283–295. doi: 10.1016/j.immuni.2009.06.021. [DOI] [PubMed] [Google Scholar]
- 81.Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, Kaech SM. Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity. 2009;31(2):296–308. doi: 10.1016/j.immuni.2009.05.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Becker TC, Wherry EJ, Boone D, Murali-Krishna K, Antia R, Ma A, Ahmed R. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 2002;195(12):1541–1548. doi: 10.1084/jem.20020369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Judge AD, Zhang X, Fujii H, Surh CD, Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med. 2002;196(7):935–946. doi: 10.1084/jem.20020772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657–679. doi: 10.1146/annurev.immunol.24.021605.090727. [DOI] [PubMed] [Google Scholar]
- 85.Becker TC, Coley SM, Wherry EJ, Ahmed R. Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells. J Immunol. 2005;174(3):1269–1273. doi: 10.4049/jimmunol.174.3.1269. [DOI] [PubMed] [Google Scholar]
- 86.Parretta E, Cassese G, Barba P, Santoni A, Guardiola J, Di Rosa F. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow. J Immunol. 2005;174(12):7654–7664. doi: 10.4049/jimmunol.174.12.7654. [DOI] [PubMed] [Google Scholar]
- 87.Su YC, Lee CC, Kung JT. Effector function-deficient memory CD8+ T cells clonally expand in the liver and give rise to peripheral memory CD8+ T cells. J Immunol. 2010;185(12):7498–7506. doi: 10.4049/jimmunol.1002606. [DOI] [PubMed] [Google Scholar]
- 88.Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA. Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med. 2002;195(12):1515–1522. doi: 10.1084/jem.20020033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, Brasel K, Morrissey PJ, Stocking K, Schuh JC, Joyce S, Peschon JJ. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med. 2000;191(5):771–780. doi: 10.1084/jem.191.5.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, Ma A. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 1998;9(5):669–676. doi: 10.1016/s1074-7613(00)80664-0. [DOI] [PubMed] [Google Scholar]
- 91.Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha} Proc Natl Acad Sci USA. 2006;103(24):9166–9171. doi: 10.1073/pnas.0600240103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Stoklasek TA, Schluns KS, Lefrancois L. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol. 2006;177(9):6072–6080. doi: 10.4049/jimmunol.177.9.6072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, Matsuguchi T, Suzuki M, Ohashi PS, Yoshikai Y. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med. 2000;191(1):157–170. doi: 10.1084/jem.191.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, Waldmann TA, Tagaya Y. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA. 2000;97(21):11445–11450. doi: 10.1073/pnas.200363097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Fehniger TA, Suzuki K, Ponnappan A, VanDeusen JB, Cooper MA, Florea SM, Freud AG, Robinson ML, Durbin J, Caligiuri MA. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med. 2001;193(2):219–231. doi: 10.1084/jem.193.2.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Yajima T, Yoshihara K, Nakazato K, Kumabe S, Koyasu S, Sad S, Shen H, Kuwano H, Yoshikai Y. IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol. 2006;176(1):507–515. doi: 10.4049/jimmunol.176.1.507. [DOI] [PubMed] [Google Scholar]
- 97.Moroz A, Eppolito C, Li Q, Tao J, Clegg CH, Shrikant PA. IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21. J Immunol. 2004;173(2):900–909. doi: 10.4049/jimmunol.173.2.900. [DOI] [PubMed] [Google Scholar]
- 98.Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS, Pise-Masison CA, Radonovich MF, Brady JN, Restifo NP, Berzofsky JA, Leonard WJ. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J Exp Med. 2005;201(1):139–148. doi: 10.1084/jem.20041057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Allard EL, Hardy MP, Leignadier J, Marquis M, Rooney J, Lehoux D, Labrecque N. Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol. 2007;37(11):3069–3077. doi: 10.1002/eji.200637017. [DOI] [PubMed] [Google Scholar]
- 100.Novy P, Huang X, Leonard WJ, Yang Y. Intrinsic IL-21 signaling is critical for CD8 T Cell survival and memory formation in response to vaccinia viral infection. J Immunol. 2011;186(5):2729–2738. doi: 10.4049/jimmunol.1003009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Elsaesser H, Sauer K, Brooks DG. IL-21 is required to control chronic viral infection. Science. 2009;324(5934):1569–1572. doi: 10.1126/science.1174182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Yi JS, Du M, Zajac AJ. A vital role for interleukin-21 in the control of a chronic viral infection. Science. 2009;324(5934):1572–1576. doi: 10.1126/science.1175194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Frohlich A, Kisielow J, Schmitz I, Freigang S, Shamshiev AT, Weber J, Marsland BJ, Oxenius A, Kopf M. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science. 2009;324(5934):1576–1580. doi: 10.1126/science.1172815. [DOI] [PubMed] [Google Scholar]
- 104.Kieper WC, Tan JT, Bondi-Boyd B, Gapin L, Sprent J, Ceredig R, Surh CD. Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells. J Exp Med. 2002;195(12):1533–1539. doi: 10.1084/jem.20020067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Chappaz S, Flueck L, Farr AG, Rolink AG, Finke D. Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. Blood. 2007;110(12):3862–3870. doi: 10.1182/blood-2007-02-074245. [DOI] [PubMed] [Google Scholar]
- 106.Rochman Y, Leonard WJ. The role of thymic stromal lymphopoietin in CD8+ T cell homeostasis. J Immunol. 2008;181(11):7699–7705. doi: 10.4049/jimmunol.181.11.7699. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Min B, McHugh R, Sempowski GD, Mackall C, Foucras G, Paul WE. Neonates support lymphopenia-induced proliferation. Immunity. 2003;18(1):131–140. doi: 10.1016/s1074-7613(02)00508-3. [DOI] [PubMed] [Google Scholar]
- 108.Guimond M, Veenstra RG, Grindler DJ, Zhang H, Cui Y, Murphy RD, Kim SY, Na R, Hennighausen L, Kurtulus S, Erman B, Matzinger P, Merchant MS, Mackall CL. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells. Nat Immunol. 2009;10(2):149–157. doi: 10.1038/ni.1695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 1999;11(2):173–181. doi: 10.1016/s1074-7613(00)80092-8. [DOI] [PubMed] [Google Scholar]
- 110.Goldrath AW, Bevan MJ. Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity. 1999;11(2):183–190. doi: 10.1016/s1074-7613(00)80093-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Kieper WC, Jameson SC. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc Natl Acad Sci USA. 1999;96(23):13306–13311. doi: 10.1073/pnas.96.23.13306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Almeida AR, Rocha B, Freitas AA, Tanchot C. Homeostasis of T cell numbers: from thymus production to peripheral compartmentalization and the indexation of regulatory T cells. Semin Immunol. 2005;17(3):239–249. doi: 10.1016/j.smim.2005.02.002. [DOI] [PubMed] [Google Scholar]
- 113.Hamilton SE, Wolkers MC, Schoenberger SP, Jameson SC. The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells. Nat Immunol. 2006;7(5):475–481. doi: 10.1038/ni1326. [DOI] [PubMed] [Google Scholar]
- 114.Haluszczak C, Akue AD, Hamilton SE, Johnson LD, Pujanauski L, Teodorovic L, Jameson SC, Kedl RM. The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med. 2009;206(2):435–448. doi: 10.1084/jem.20081829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Davey GM, Starr R, Cornish AL, Burghardt JT, Alexander WS, Carbone FR, Surh CD, Heath WR. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med. 2005;202(8):1099–1108. doi: 10.1084/jem.20050003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Ramanathan S, Gagnon J, Leblanc C, Rottapel R, Ilangumaran S. Suppressor of cytokine signaling 1 stringently regulates distinct functions of IL-7 and IL-15 in vivo during T lymphocyte development and homeostasis. J Immunol. 2006;176(7):4029–4041. doi: 10.4049/jimmunol.176.7.4029. [DOI] [PubMed] [Google Scholar]
- 117.Cho JH, Boyman O, Kim HO, Hahm B, Rubinstein MP, Ramsey C, Kim DM, Surh CD, Sprent J. An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2. J Exp Med. 2007;204(8):1787–1801. doi: 10.1084/jem.20070740. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Workman CJ, Vignali DA. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223) J Immunol. 2005;174(2):688–695. doi: 10.4049/jimmunol.174.2.688. [DOI] [PubMed] [Google Scholar]
- 119.Posevitz V, Arndt B, Krieger T, Warnecke N, Schraven B, Simeoni L. Regulation of T cell homeostasis by the transmembrane adaptor protein SIT. J Immunol. 2008;180(3):1634–1642. doi: 10.4049/jimmunol.180.3.1634. [DOI] [PubMed] [Google Scholar]
- 120.Li O, Zheng P, Liu Y. CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host. J Exp Med. 2004;200(8):1083–1089. doi: 10.1084/jem.20040779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med. 2005;202(5):637–650. doi: 10.1084/jem.20050821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Havenar-Daughton C, Kolumam GA, Murali-Krishna K. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol. 2006;176(6):3315–3319. doi: 10.4049/jimmunol.176.6.3315. [DOI] [PubMed] [Google Scholar]
- 123.Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol. 2009;182(5):2786–2794. doi: 10.4049/jimmunol.0803484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Bahl K, Kim SK, Calcagno C, Ghersi D, Puzone R, Celada F, Selin LK, Welsh RM. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol. 2006;176(7):4284–4295. doi: 10.4049/jimmunol.176.7.4284. [DOI] [PubMed] [Google Scholar]
- 125.Whitmire JK, Tan JT, Whitton JL. Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J Exp Med. 2005;201(7):1053–1059. doi: 10.1084/jem.20041463. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Whitmire JK, Benning N, Whitton JL. Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+ T cell responses. J Immunol. 2005;175(9):5624–5628. doi: 10.4049/jimmunol.175.9.5624. [DOI] [PubMed] [Google Scholar]
- 127.O’Shea JJ, Paul WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science. 2010;327(5969):1098–1102. doi: 10.1126/science.1178334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Foulds KE, Rotte MJ, Seder RA. IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. J Immunol. 2006;177(4):2565–2574. doi: 10.4049/jimmunol.177.4.2565. [DOI] [PubMed] [Google Scholar]
- 129.Kang SS, Allen PM. Priming in the presence of IL-10 results in direct enhancement of CD8+ T cell primary responses and inhibition of secondary responses. J Immunol. 2005;174(9):5382–5389. doi: 10.4049/jimmunol.174.9.5382. [DOI] [PubMed] [Google Scholar]
- 130.Brooks DG, Trifilo MJ, Edelmann KH, Teyton L, McGavern DB, Oldstone MB. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006;12(11):1301–1309. doi: 10.1038/nm1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Ejrnaes M, Filippi CM, Martinic MM, Ling EM, Togher LM, Crotty S, von Herrath MG. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006;203(11):2461–2472. doi: 10.1084/jem.20061462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25(3):455–471. doi: 10.1016/j.immuni.2006.07.011. [DOI] [PubMed] [Google Scholar]
- 133.Tinoco R, Alcalde V, Yang Y, Sauer K, Zuniga EI. Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. Immunity. 2009;31(1):145–157. doi: 10.1016/j.immuni.2009.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Bonneville M, O’Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10(7):467–478. doi: 10.1038/nri2781. [DOI] [PubMed] [Google Scholar]
- 135.Jameson J, Havran WL. Skin gammadelta T-cell functions in homeostasis and wound healing. Immunol Rev. 2007;215:114–122. doi: 10.1111/j.1600-065X.2006.00483.x. [DOI] [PubMed] [Google Scholar]
- 136.Laky K, Lewis JM, Tigelaar RE, Puddington L. Distinct requirements for IL-7 in development of TCR gamma delta cells during fetal and adult life. J Immunol. 2003;170(8):4087–4094. doi: 10.4049/jimmunol.170.8.4087. [DOI] [PubMed] [Google Scholar]
- 137.De Creus A, Van Beneden K, Stevenaert F, Debacker V, Plum J, Leclercq G. Developmental and functional defects of thymic and epidermal V gamma 3 cells in IL-15-deficient and IFN regulatory factor-1-deficient mice. J Immunol. 2002;168(12):6486–6493. doi: 10.4049/jimmunol.168.12.6486. [DOI] [PubMed] [Google Scholar]
- 138.Schluns KS, Nowak EC, Cabrera-Hernandez A, Puddington L, Lefrancois L, Aguila HL. Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression. Proc Natl Acad Sci USA. 2004;101(15):5616–5621. doi: 10.1073/pnas.0307442101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Yu Q, Tang C, Xun S, Yajima T, Takeda K, Yoshikai Y. MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8 alpha alpha TCR alpha beta and TCR gamma delta intestinal intraepithelial lymphocytes. J Immunol. 2006;176(10):6180–6185. doi: 10.4049/jimmunol.176.10.6180. [DOI] [PubMed] [Google Scholar]
- 140.Baccala R, Witherden D, Gonzalez-Quintial R, Dummer W, Surh CD, Havran WL, Theofilopoulos AN. Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J Immunol. 2005;174(8):4606–4612. doi: 10.4049/jimmunol.174.8.4606. [DOI] [PubMed] [Google Scholar]
- 141.French JD, Roark CL, Born WK, O’Brien RL. gamma}{delta T cell homeostasis is established in competition with alpha}{beta T cells and NK cells. Proc Natl Acad Sci USA. 2005;102(41):14741–14746. doi: 10.1073/pnas.0507520102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.French JD, Roark CL, Born WK, O’Brien RL. Gammadelta T lymphocyte homeostasis is negatively regulated by beta2-microglobulin. J Immunol. 2009;182(4):1892–1900. doi: 10.4049/jimmunol.0803165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Boyman O, Surh CD, Sprent J. Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease. Expert Opin Biol Ther. 2006;6(12):1001–1009. doi: 10.1517/14712598.6.12.1323. [DOI] [PubMed] [Google Scholar]
- 144.Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 2003;197(8):967–976. doi: 10.1084/jem.20021847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP. Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol. 2005;174(3):1213–1221. doi: 10.4049/jimmunol.174.3.1213. [DOI] [PubMed] [Google Scholar]
- 146.Kasaian MT, Whitters MJ, Carter LL, Lowe LD, Jussif JM, Deng B, Johnson KA, Witek JS, Senices M, Konz RF, Wurster AL, Donaldson DD, Collins M, Young DA, Grusby MJ. IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity. 2002;16(4):559–569. doi: 10.1016/s1074-7613(02)00295-9. [DOI] [PubMed] [Google Scholar]
- 147.Sun JC, Beilke JN, Bezman NA, Lanier LL. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med. 2010;208(2):357–368. doi: 10.1084/jem.20100479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Huntington ND, Tabarias H, Fairfax K, Brady J, Hayakawa Y, Degli-Esposti MA, Smyth MJ, Tarlinton DM, Nutt SL. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178(8):4764–4770. doi: 10.4049/jimmunol.178.8.4764. [DOI] [PubMed] [Google Scholar]
- 149.Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol. 2004;172(2):864–870. doi: 10.4049/jimmunol.172.2.864. [DOI] [PubMed] [Google Scholar]
- 150.Purton JF, Tan JT, Rubinstein MP, Kim DM, Sprent J, Surh CD. Antiviral CD4+ memory T cells are IL-15 dependent. J Exp Med. 2007;204(4):951–961. doi: 10.1084/jem.20061805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Homann D, Teyton L, Oldstone MB. Differential regulation of antiviral T-cell immunity results in stable CD8 + but declining CD4+ T-cell memory. Nat Med. 2001;7(8):913–919. doi: 10.1038/90950. [DOI] [PubMed] [Google Scholar]
- 152.Schiemann M, Busch V, Linkemann K, Huster KM, Busch DH. Differences in maintenance of CD8+ and CD4+ bacteria-specific effector-memory T cell populations. Eur J Immunol. 2003;33(10):2875–2885. doi: 10.1002/eji.200324224. [DOI] [PubMed] [Google Scholar]
- 153.Imamichi H, Sereti I, Lane HC. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3. Eur J Immunol. 2008;38(6):1621–1630. doi: 10.1002/eji.200737607. [DOI] [PMC free article] [PubMed] [Google Scholar]



